This inventor holds 1 USPTO granted patent. Top assignees: Universitè De Genève, Unversität Zürich. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 72 
1 out of 276 
Years Active: 2014
Title: Innovator Caroline Pot Kreis: Pioneering Diabetes Treatments
Introduction: Caroline Pot Kreis, an accomplished inventor based in Geneva, Switzerland, has made significant contributions to the field of medical science. With her innovative work, she aims to address critical health issues, particularly in managing diabetes mellitus. Her dedication to research and development has led to the creation of a groundbreaking patent that offers promising solutions for blood glucose and insulin level control.
Latest Patents: Caroline Pot Kreis holds one notable patent titled “Uses of NOGO-A inhibitors and related methods.” This patent encompasses Nogo-A antagonists that are useful for controlling blood glucose or insulin levels in subjects. The invention focuses on preventing, repressing, or treating insulin secretion deficiency, along with developing related methods and pharmaceutical formulations. This innovative approach prepares the groundwork for advancements in diabetes treatment.
Career Highlights: Throughout her career, Caroline has associated with prestigious institutions, such as the University of Zurich and the University of Geneva. Her work in these renowned organizations has underpinned her research and led to her patent developments. Caroline's expertise and commitment to innovation in medical science underscore her influential role in the industry.
Collaborations: Caroline Pot Kreis has collaborated with esteemed colleagues, including Pedro L. Herrera and Martin E. Schwab. These partnerships strengthen her research initiatives and extend the reach of her innovative discoveries in the field of diabetes management.
Conclusion: The achievements of Caroline Pot Kreis exemplify the spirit of innovation in addressing health challenges. Her patent on Nogo-A antagonists showcases her dedication to improving treatment options for diabetes mellitus. As she continues her work, her inventions hold the potential to transform the landscape of diabetes care, benefiting countless individuals around the world.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile